Medics want thalidomide to be tested further in idiopathic pulmonary fibrosis
This article was originally published in Scrip
Executive Summary
US doctors are calling for larger trials investigating Celgene's thalidomide (Thalomid) in patients with idiopathic pulmonary fibrosis (IPF) after a short and small study investigating the drug in this patient set suggested it reduces cough and improves quality of life.